Worsening of bruxism with atomoxetine: A case report

World Journal of Biological Psychiatry

Volumn 10, Issue 4 PART 2, 2009, Pages 671-672

  Mendhekar, Dattatreya ^a   Lohia, Deep ^b  

^a Neuropsychiatry and Headache Clinic   (India)

^b ELMHURST HOSPITAL CENTER   (United States)

Author keywords

ADHD; Adverse effects; Childhood ADHD; Side effects

Indexed keywords

ATOMOXETINE; BUSPIRONE; ADRENERGIC RECEPTOR AFFECTING AGENT; PROPYLAMINE;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; BRUXISM; CASE REPORT; CHILD; CLINICAL EXAMINATION; DISEASE EXACERBATION; DRUG WITHDRAWAL; HUMAN; MALE; SCHOOL CHILD; ATTENTION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; FOLLOW UP; PSYCHOLOGICAL ASPECT;

ADRENERGIC UPTAKE INHIBITORS; ADVERSE DRUG REACTION REPORTING SYSTEMS; ATTENTION; BRUXISM; CHILD; FOLLOW-UP STUDIES; HUMANS; MALE; PROPYLAMINES;

EID: 77449093612     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970802576488     Document Type: Article

References (5)

1. Manos MJ, Tom-Revzon C, Bukstein OG, Crismon ML. 2005. Changes and challenges: managing ADHD in a fast-paced world. J Manag Care Pharm 13:S2-13.
2. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. 1981. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239-245. (Pubitemid 12149145)
3. Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, et al. 2006. The Texas Children's Medication Algorithm Project: Revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45:642-657.
4. Strattera (atomoxetine). Prescribing information. 2007. Indianapolis, IN: Eli Lilly and Company.
5. Winocur E, Gavish A, Voikovitch M, Emodi-Prlman A, Eli I. 2003. Drugs and bruxism: A critical review. J Orofac Pain 17:99-111.